Synthetic Survival Control: Extending Synthetic Controls for "When-If" Decision

📅 2025-11-17
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Estimating the causal effect of interventions on time-to-event outcomes from observational data faces challenges including censoring, small sample sizes, and non-random treatment assignment—particularly hindering answers to “when-if” questions (e.g., “When would the event occur if intervention were applied at a given time?”). This paper introduces Synthetic Survival Control (SSC), the first extension of the synthetic control framework to survival analysis. SSC formulates a low-rank panel causal model for survival data, enabling nonparametric identification of counterfactual hazard trajectories with finite-sample theoretical guarantees. By integrating parametric survival modeling with weighted synthetic controls, SSC reconstructs the target unit’s counterfactual hazard path using untreated units. Empirical evaluation on multi-country clinical oncology data demonstrates that improved access to novel therapies significantly reduces hazard rates and extends overall survival, while maintaining interpretability and practical utility.

Technology Category

Application Category

📝 Abstract
Estimating causal effects on time-to-event outcomes from observational data is particularly challenging due to censoring, limited sample sizes, and non-random treatment assignment. The need for answering such "when-if" questions--how the timing of an event would change under a specified intervention--commonly arises in real-world settings with heterogeneous treatment adoption and confounding. To address these challenges, we propose Synthetic Survival Control (SSC) to estimate counterfactual hazard trajectories in a panel data setting where multiple units experience potentially different treatments over multiple periods. In such a setting, SSC estimates the counterfactual hazard trajectory for a unit of interest as a weighted combination of the observed trajectories from other units. To provide formal justification, we introduce a panel framework with a low-rank structure for causal survival analysis. Indeed, such a structure naturally arises under classical parametric survival models. Within this framework, for the causal estimand of interest, we establish identification and finite sample guarantees for SSC. We validate our approach using a multi-country clinical dataset of cancer treatment outcomes, where the staggered introduction of new therapies creates a quasi-experimental setting. Empirically, we find that access to novel treatments is associated with improved survival, as reflected by lower post-intervention hazard trajectories relative to their synthetic counterparts. Given the broad relevance of survival analysis across medicine, economics, and public policy, our framework offers a general and interpretable tool for counterfactual survival inference using observational data.
Problem

Research questions and friction points this paper is trying to address.

Estimating causal effects on time-to-event outcomes with censoring and confounding
Answering when-if questions about event timing under specific interventions
Extending synthetic controls for counterfactual hazard trajectory estimation
Innovation

Methods, ideas, or system contributions that make the work stand out.

SSC estimates counterfactual hazard trajectories via weighted combinations
Introduces low-rank panel framework for causal survival analysis
Provides identification guarantees and finite sample guarantees
🔎 Similar Papers
No similar papers found.